Log in
Login
Password
Remember
Lost password
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  Shares  >  Nasdaq  >  Genomic Health, Inc.    GHDX   US37244C1018

 SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq
06/30/2015 07/01/2015 07/02/2015 07/06/2015 07/07/2015 Date
27.79(c) 27.34(c) 27.11(c) 27.53(c) 27.72 Last
135 759 157 922 105 336 106 286 53 191 Volume
+3.69% -1.62% -0.84% +1.55% +0.69% Change
More quotes
Financials ($)
Sales 2015 293 M
EBIT 2015 -27,9 M
Net income 2015 -23,8 M
Finance 2015 120 M
Yield 2015 -
Sales 2016 336 M
EBIT 2016 2,81 M
Net income 2016 2,10 M
Finance 2016 151 M
Yield 2016 -
PER 2015 -
PER 2016 540,86
EV / Sales 2015 2,62x
EV / Sales 2016 2,19x
Capitalization 888 M
More Financials
Company
Genomic Health, Inc. is a global healthcare company that provides actionable genomic information to personalize cancer treatment decisions.The company has a robust pipeline focused on developing tests to optimize the treatment of renal cell cancers, as well as additional treatment decisions in... 
More about the company
Surperformance© ratings of Genomic Health, Inc.
Trading Rating : Investor Rating :
More Ratings
Latest news on GENOMIC HEALTH, INC.
07/01 GENOMIC HEALTH : Journal of Surgical Oncology Publishes Study Showing Oncotype D..
06/24 GENOMIC HEALTH : Presents Positive Proof-of-Concept Data for Bladder Cancer Liqu..
06/23 GENOMIC HEALTH : Journal of Surgical Oncology Publishes Study Showing Oncotype D..
06/17 GENOMIC HEALTH : Submission of Matters to a Vote of Security Holders (form 8-K)
06/17 GENOMIC HEALTH : to Present Proof-of-Concept Bladder Cancer Liquid Biopsy Data a..
06/16 GENOMIC HEALTH : Presents Positive Proof-of-Concept Data for Bladder Cancer Liqu..
06/11 GENOMIC HEALTH : Oncotype DX® Presentations at ASCO in Breast and Prostate Cance..
06/11 GENOMIC HEALTH : to Present Proof-of-Concept Bladder Cancer Liquid Biopsy Data a..
More news
Sector news : Biotechnology & Medical Research - NEC
07:31a INCYTE : and Vanderbilt University Medical Center Establish Multi-Year Oncology ..
07:30a GENMAB A/S : Announces European Regulatory Submission for Ofatumumab as Maintena..
06:16a SHANGHAI RAAS BLOOD PRODUCTS : Controller Kicks Off Holding Expansion
More sector news : Biotechnology & Medical Research - NEC
News from SeekingAlpha
05/05 Genomic Health's (GHDX) CEO Kimberly Popovits on Q1 2015 Results - Earnings C..
05/05 Genomic Health misses by $0.04, misses on revenue
05/04 Notable earnings after Tuesday?s close
05/01 NEXT WEEK IN BIOTECH : Earnings Deluge - From GSK And Achillion To Intercept And..
02/12 GENOMIC HEALTH : 2014 Financial Results Predict Strong 2015


Comments 
Advertisement
Chart GENOMIC HEALTH, INC.
Duration : Period :
Genomic Health, Inc. Technical Analysis Chart | GHDX | US37244C1018 | 4-Traders
Full-screen chart
Technical analysis trends
Short TermMid-TermLong Term
TrendsNeutralBearishNeutral
Technical analysis
Income Statement Evolution
More Financials
EPS Revisions
More Estimates Revisions